NCT00543413 A Study to Determine the Effectiveness and Tolerability of MK8141 in Patients With High Blood Pressure (MK-8141-006) Status COMPLETED Phase PHASE2
NCT00543387 Treatment of Participants With Advanced and/or Refractory Solid Tumors (MK-5108-001) Status COMPLETED Phase PHASE1
NCT00543361 Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020) Status TERMINATED Phase PHASE3
NCT00543010 MK0767 Glipizide Comparator Cardiac Safety Study (0767-018) Status TERMINATED Phase PHASE3
NCT00542022 Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008) Status COMPLETED Phase PHASE2
NCT00541775 Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801) Status COMPLETED Phase PHASE3
NCT00541463 A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED) Status COMPLETED Phase PHASE2
NCT00541450 A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00541229 Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00539968 A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED) Status TERMINATED Phase PHASE1/PHASE2
NCT00539721 A Randomized Controlled Study of Rolapitant for the Prevention of Nausea and Vomiting Following Surgery (Study P04937AM1)(COMPLETED) Status COMPLETED Phase PHASE2
NCT00538239 Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Ridaforolimus)(8669-011 AM6) Status COMPLETED Phase PHASE3
NCT00537316 Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807) Status TERMINATED Phase PHASE3
NCT00537121 Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer Status COMPLETED Phase PHASE1
NCT00537017 Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175) Status COMPLETED Phase PHASE2
NCT00536588 A Safety and Tolerability Study of SCH 721015 in Patients With Transitional Cell Carcinoma of the Bladder (Study P03816) Status COMPLETED Phase PHASE1
NCT00536263 PegIntron Treatment of Chronic Hepatitis B e Antigen-Positive Patients (P05170/MK-4031-327) Status COMPLETED Phase PHASE3